| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56179SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56682SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47704-0.1mg | |||
| IHC-Prediluted | NBP2-48345 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43299-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63062-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76614-0.025mg | |||
![Western Blot: RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - Inhibits TNF-induced NF-kB activation: KBM-5 cells were incubated with various concentrations of peptides for 1 hr and treated with 0.1nM TNF for 30min. Nuclear extracts were prepared and NF-kB activation was analyzed by EMSA (Please refer toTakada et al, 2004 for further details). PTD-p65-P6 suppresses TNF-induced NF-kB activation by 25% at 100 uM and completely at 150 uM, where as the control peptide, PTD or p65-P6 without PTD did not have any effect.](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser529--p-Ser536]-Inhibitor-Peptide-Set-Western-Blot-NBP2-29321-img0015.jpg "<b>Biological Strategies Validation. </b>Western Blot: RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - Inhibits TNF-induced NF-kB activation: KBM-5 cells were incubated with various concentrations of peptides for 1 hr and treated with 0.1nM TNF for 30min. Nuclear extracts were prepared and NF-kB activation was analyzed by EMSA (Please refer toTakada et al, 2004 for further details). PTD-p65-P6 suppresses TNF-induced NF-kB activation by 25% at 100 uM and completely at 150 uM, where as the control peptide, PTD or p65-P6 without PTD did not have any effect.")
![<b>Biological Strategies Validation. </b>Western Blot: RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - Effect of various p65-inhibitor peptides on binding of purified recombinant p65 protein to the DNA in vitro. Recombinant p65 protein (100 ng/sample) was incubated for 30 minutes with 50uM of various peptides in 0.025 ml and then assayed for DNA binding activity by EMSA (Please refer to Takada et al, 2004 (3) for further details).](http://images.novusbio.com/fullsize/RelA-NFkB-p65-[p-Ser529--p-Ser536]-Inhibitor-Peptide-Set-Western-Blot-NBP2-29321-img0013.jpg)
![Functional (Inhibition): RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set [NBP2-29321] - TLR5/NF-kB/SEAPorter HEK 293 (NBP2-26277) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were preincubated with different concentrations (0, 1, 5, 10, 25 and 50 uM) of Inhibitory Peptide (NBP2-29321) and Control Peptide (NBP2-29334) for 1 h. Cells were then stimulated with 1 ng/ml Flagellin (NBP2-25289) for 24 h. Secreted alkaline phosphatase (SEAP) was analyzed using SEAPorter Assay Kit (NBP2-25285). *p < 0.05 versus control peptide at the corresponding concentrations (Mann-Whitney U test).](http://images.novusbio.com/fullsize/RelA-NFkB-p65-p-Ser529-p-Ser536-Inhibitor-Peptide-Set-Functional-Inhibition-NBP2-29321-img0012.jpg)
![Flow Cytometry: MHC Class II Antibody (M5/114) - Azide Free [NBP2-21789] - Staining of MHCII on murine splenocytes with anti-MHCII (M5/114) azide free, GAR-APC.](http://images.novusbio.com/fullsize/MHC-Class-II-Antibody-M5-114-Azide-Free-Flow-Cytometry-NBP2-21789-img0001.jpg "Flow Cytometry: MHC Class II Antibody (M5/114) - Azide Free [NBP2-21789] - Staining of MHCII on murine splenocytes with anti-MHCII (M5/114) azide free, GAR-APC.")
![Western Blot: CCR2 Antibody (SN707) [NBP2-67700] - Analysis of CCR2 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: Mouse spleen tissue lysateLane 2: THP-1 cell lysate](http://images.novusbio.com/fullsize/CCR2-Antibody-SN707-Western-Blot-NBP2-67700-img0004.jpg "Western Blot: CCR2 Antibody (SN707) [NBP2-67700] - Analysis of CCR2 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: Mouse spleen tissue lysateLane 2: THP-1 cell lysate")
![Immunohistochemistry-Paraffin: CCR2 Antibody (SN707) [NBP2-67700] - Analysis of paraffin-embedded human esophagus tissue with Rabbit anti-CCR2 antibody washed with ddH2O and PBS, and then probed with the primary antibody at 1/400 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/CCR2-Antibody-SN707-Immunohistochemistry-Paraffin-NBP2-67700-img0005.jpg)
![Flow Cytometry: CCR2 Antibody (SN707) [NBP2-67700] - Analysis of K562 cells with CCR2 antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody](http://images.novusbio.com/fullsize/CCR2-Antibody-SN707-Flow-Cytometry-NBP2-67700-img0001.jpg)
![Immunohistochemistry-Paraffin: CCR2 Antibody (SN707) [NBP2-67700] - Analysis of paraffin-embedded human breast carcinoma tissue using anti-CCR2 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CCR2-Antibody-SN707-Immunohistochemistry-Paraffin-NBP2-67700-img0002.jpg)
![Immunohistochemistry-Paraffin: CCR2 Antibody (SN707) [NBP2-67700] - Analysis of paraffin-embedded human tonsil tissue using anti-CCR2 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CCR2-Antibody-SN707-Immunohistochemistry-Paraffin-NBP2-67700-img0003.jpg)
![Flow Cytometry: TCR alpha/beta Antibody (R73) [NBP2-12941] - Rat splenocytes with anti-rat TCR alpha/beta (R73) FITC.](http://images.novusbio.com/fullsize/TCR-alpha-beta-Antibody-R73-Flow-Cytometry-NBP2-12941-img0002.jpg "Flow Cytometry: TCR alpha/beta Antibody (R73) [NBP2-12941] - Rat splenocytes with anti-rat TCR alpha/beta (R73) FITC.")
![Flow Cytometry: TCR alpha/beta Antibody (R73) [NBP2-12941] - Rat thymocytes with anti-rat TCR alpha/beta (R73) PE.](http://images.novusbio.com/fullsize/TCR-alpha-beta-Antibody-R73-Flow-Cytometry-NBP2-12941-img0001.jpg)
![Western Blot: TRAF-6 Antibody [NB100-56179] - Analysis of TRAF-6 in normal Human tissues using this antibody. TRAF6 is observed at ~66 kDa. Additional bands of lower molecular weight were seen in some cases, and may represent TRAF-6 degradation fragments.](http://images.novusbio.com/fullsize/TRAF-6-Antibody-Western-Blot-NB100-56179-img0011.jpg "Western Blot: TRAF-6 Antibody [NB100-56179] - Analysis of TRAF-6 in normal Human tissues using this antibody. TRAF6 is observed at ~66 kDa. Additional bands of lower molecular weight were seen in some cases, and may represent TRAF-6 degradation fragments.")
![Immunohistochemistry-Paraffin: TRAF-6 Antibody [NB100-56179] - Stained for TRAF6 using this antibody at 1:2000. Hematoxylin-eosin counterstain. A, mouse spleen. B, mouse thymus.](http://images.novusbio.com/fullsize/TRAF-6-Antibody-Immunohistochemistry-Paraffin-NB100-56179-img0008.jpg)
![Immunohistochemistry-Paraffin: TRAF-6 Antibody [NB100-56179] - 1:2000. Analysis Hematoxylin-eosin counterstain. A, mouse lymph node. B, mouse bone marrow.](http://images.novusbio.com/fullsize/TRAF-6-Antibody-Immunohistochemistry-Paraffin-NB100-56179-img0007.jpg)
![Western Blot: RPL7 Antibody [NB100-2269] - Detection of human and mouse RPL7 by western blot. Samples: Whole cell lysate (50 ug) from HeLa, HEK293T, Jurkat, mouse TMCK-1, and mouse NIH 3T3 cells prepared using RIPA lysis buffer. Antibody: Affinity purified rabbit anti-RPL7 antibody NB100-2269 used for WB at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 3 seconds.](http://images.novusbio.com/fullsize/RPL7-Antibody-Western-Blot-NB100-2269-img0016.jpg "Western Blot: RPL7 Antibody [NB100-2269] - Detection of human and mouse RPL7 by western blot. Samples: Whole cell lysate (50 ug) from HeLa, HEK293T, Jurkat, mouse TMCK-1, and mouse NIH 3T3 cells prepared using RIPA lysis buffer. Antibody: Affinity purified rabbit anti-RPL7 antibody NB100-2269 used for WB at 0.04 ug/ml. Detection: Chemiluminescence with an exposure time of 3 seconds.")
![Immunohistochemistry-Paraffin: RPL7 Antibody [NB100-2269] - Mouse renal cell carcinoma. Antibody: Affinity purified rabbit anti-RPL7 used at a dilution of 1:1,000 (0.2ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/RPL7-Antibody-Immunohistochemistry-Paraffin-NB100-2269-img0015.jpg)
![Immunohistochemistry-Paraffin: RPL7 Antibody [NB100-2269] - Human ovarian carcinoma. Antibody: Affinity purified rabbit anti-RPL7 used at a dilution of 1:1,000 (0.2ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/RPL7-Antibody-Immunohistochemistry-Paraffin-NB100-2269-img0014.jpg)
![Immunoprecipitation: RPL7 Antibody [NB100-2269] - Detection of human RPL7 by western blot of immunoprecipitates. Samples:Whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) from HEK293T cells prepared using RIPA lysis buffer. Antibodies: Affinity purified rabbit anti-RPL7 antibody NB100-2269(lot NB100-2269-3) used for IP at 6 ug per reaction. RPL7 was also immunoprecipitated by a previous lot of this antibody (lot NB100-2269-2). For blotting immunoprecipitated RPL7, NB100-2269 was used at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 1 second.](http://images.novusbio.com/fullsize/RPL7-Antibody-Immunoprecipitation-NB100-2269-img0017.jpg)
![Western Blot: TLR7 Antibody [NB100-56682] - Analysis of TLR7 in Ramos cell lysate using NB100-56682 at 1:500.](http://images.novusbio.com/fullsize/TLR7-Antibody-Western-Blot-NB100-56682-img0003.jpg)
![Immunohistochemistry-Paraffin: TLR7 Antibody [NB100-56682] - Analysis of TLR7 in formalin-fixed, paraffin-embedded human lung tissue using an isotype control (top) and this antibody (bottom) at 1:100.](http://images.novusbio.com/fullsize/TLR7-Antibody-Immunohistochemistry-Paraffin-NB100-56682-img0004.jpg)
![Western Blot: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Western Blot Analysis of THP-1 and Raji cell lysates using beta 2-Microglobulin antibody (B2M/961).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Western-Blot-NBP2-44471-img0017.jpg "Western Blot: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Western Blot Analysis of THP-1 and Raji cell lysates using beta 2-Microglobulin antibody (B2M/961).")
![Immunocytochemistry/Immunofluorescence: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Immunofluorescence Analysis of HeLa cells labeling with beta 2-Microglobulin Antibody (B2M/961) followed by Goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunocytochemistry-Immunofluorescence-NBP2-44471-img0010.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Formalin-fixed, paraffin-embedded human Cervical Carcinoma stained with beta 2-Microglobulin Antibody (B2M/961).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0013.jpg)
![Flow Cytometry: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Flow Cytometric Analysis of Human HeLa cells. beta 2-Microglobulin Antibody (B2M/961) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype control (Red)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Flow-Cytometry-NBP2-44471-img0009.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Bladder Carcinoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0001.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Cervical Carcinoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0002.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Cervical Carcinoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0003.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Colon Carcinoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0004.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Endometrial Carcinoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0005.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Melanoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0006.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Human Renal Carcinoma stained with Beta-2-Microglobulin Monoclonal Antibody (B2M/961)](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0007.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Formalin-fixed, paraffin-embedded human Gastric Carcinoma stained with beta 2-Microglobulin Antibody (B2M/961).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0011.jpg)
![Immunohistochemistry-Paraffin: beta 2-Microglobulin Antibody (B2M/961) [NBP2-44471] - Formalin-fixed, paraffin-embedded human Cervical Carcinoma stained with beta 2-Microglobulin Antibody (B2M/961).](http://images.novusbio.com/fullsize/beta-2-Microglobulin-Antibody-B2M-961-Immunohistochemistry-Paraffin-NBP2-44471-img0012.jpg)
![Western Blot: T-bet/TBX21 Antibody (39D) [NBP1-43299] - CD4+ T cells were sorted from mouse splenocytes, then activated with Anti-Mouse CD3 and Anti-Mouse CD28, followed by culture in Th1-polarizing conditions, and re-stimulation with PMA and Ionomycin. Lysates from control (left) or PMA and Ionomycin-re-stimulated (right) cells were probed with Anti-T-bet Purified at 2 ug/ml, and revealed with Anti-Mouse IgG HRP.](http://images.novusbio.com/fullsize/T-bet-TBX21-Antibody-39D-Western-Blot-NBP1-43299-img0004.jpg "Western Blot: T-bet/TBX21 Antibody (39D) [NBP1-43299] - CD4+ T cells were sorted from mouse splenocytes, then activated with Anti-Mouse CD3 and Anti-Mouse CD28, followed by culture in Th1-polarizing conditions, and re-stimulation with PMA and Ionomycin. Lysates from control (left) or PMA and Ionomycin-re-stimulated (right) cells were probed with Anti-T-bet Purified at 2 ug/ml, and revealed with Anti-Mouse IgG HRP.")
![CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Lysozyme-Antibody-BGN-0696-5B1-CyTOF-ready-NB100-63062-img0001.jpg "CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.")
![Western Blot: ACE-2 Antibody [NBP1-76614] - Independent Antibody Validation (IAV) via Protein Expression Profile in Human TissuesLoading: 15 ug of lysates per lane.Antibodies: ACE2, (2 ug/mL), ACE2, (2 ug/mL), ACE2, (2 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/ACE-2-Antibody-Western-Blot-NBP1-76614-img0009.jpg "Western Blot: ACE-2 Antibody [NBP1-76614] - Independent Antibody Validation (IAV) via Protein Expression Profile in Human TissuesLoading: 15 ug of lysates per lane.Antibodies: ACE2, (2 ug/mL), ACE2, (2 ug/mL), ACE2, (2 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Immunohistochemistry-Paraffin: ACE-2 Antibody [NBP1-76614] - Analysis of paraffin-embedded human kidney tissue using anti-ACE2 antibody 2 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/ACE-2-Antibody-Immunohistochemistry-Paraffin-NBP1-76614-img0005.jpg)
![Western Blot: ACE-2 Antibody [NBP1-76614] - Validation in Rat Skin Tissue Loading: 15 ug of lysates per lane.Antibodies: ACE2 (2 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/ACE-2-Antibody-Western-Blot-NBP1-76614-img0006.jpg)
![Western Blot: ACE-2 Antibody [NBP1-76614] - Loading: 15 ug of lysates per lane.Antibodies: ACE2, (2 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/ACE-2-Antibody-Western-Blot-NBP1-76614-img0007.jpg)
![Western Blot: ACE-2 Antibody [NBP1-76614] - Validation in Human TissuesLoading: 15 ug of lysates per lane.Antibodies: ACE2, (2 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/ACE-2-Antibody-Western-Blot-NBP1-76614-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: ACE-2 Antibody [NBP1-76614] - Analysis of 4% paraformaldehyde-fixed Caco2 cells labeling ACE2 at 20 mg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue). Image showing membrane staining on Caco2 cells.](http://images.novusbio.com/fullsize/ACE-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76614-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: ACE-2 Antibody [NBP1-76614] - Analysis of 4% paraformaldehyde-fixed human lung tissue labeling ACE-2 at 20 mg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/ACE-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76614-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: ACE-2 Antibody - BSA Free [NBP1-76614] - Validation of ACE-2 in Rat Lung Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed rat lung tissue labeling ACE-2 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp1-76614_rabbit-polyclonal-ace-2-antibody-2711202420175165.gif)
![Immunocytochemistry/ Immunofluorescence: ACE-2 Antibody - BSA Free [NBP1-76614] - Validation of ACE-2 in Human Testis Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed human testis tissue labeling ACE-2 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp1-76614_rabbit-polyclonal-ace-2-antibody-2711202419514040.gif)
![Immunohistochemistry-Paraffin: CXCR6 Antibody [NLS1102] - Anti-CXCR6 antibody IHC of human Breast, Carcinoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CXCR6-Antibody-Immunohistochemistry-Paraffin-NLS1102-img0005.jpg "Immunohistochemistry-Paraffin: CXCR6 Antibody [NLS1102] - Anti-CXCR6 antibody IHC of human Breast, Carcinoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.")
![Immunohistochemistry-Paraffin: CXCR6 Antibody [NLS1102] - Analysis of anti-CXCR6 antibody with human lung, adenocarcinoma.](http://images.novusbio.com/fullsize/CXCR6-Antibody-Immunohistochemistry-Paraffin-NLS1102-img0003.jpg)
![Immunohistochemistry-Paraffin: CXCR6 Antibody [NLS1102] - Analysis of anti-CXCR6 antibody with human ovary, carcinoma.](http://images.novusbio.com/fullsize/CXCR6-Antibody-Immunohistochemistry-Paraffin-NLS1102-img0004.jpg)
![Immunohistochemistry-Paraffin: CXCR6 Antibody [NLS1102] - Analysis of anti-CXCR6 antibody with tonsil, interfollicular zone at 6.8 ug/ ml.](http://images.novusbio.com/fullsize/CXCR6-Antibody-Immunohistochemistry-Paraffin-NLS1102-img0001.jpg)
![Immunohistochemistry-Paraffin: CXCR6 Antibody - BSA Free [NLS1102] - Immunohistochemistry of formalin-fixed, paraffin-embedded Human Kidney tissue](http://images.novusbio.com/fullsize/nls1102_rabbit-cxcr6-pab-bsa-free-10920241103113.jpg)